These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3687783)

  • 21. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
    J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.
    Tavares-Silva M; Alaa M; Leite S; Oliveira-Pinto J; Lopes L; Leite-Moreira AF; Lourenço AP
    J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):485-495. PubMed ID: 28793822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
    Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
    N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome.
    Gorcsan J; Murali S; Counihan PJ; Mandarino WA; Kormos RL
    Circulation; 1996 Dec; 94(12):3190-7. PubMed ID: 8989128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial and vascular actions of milrinone.
    Colucci WS
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiologic effects of milrinone in patients with congestive heart failure.
    Goldstein RA; Geraci SA; Gray EL; Rinkenberger RL; Dougherty AH; Naccarelli GV
    Am J Cardiol; 1986 Mar; 57(8):624-8. PubMed ID: 3953448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
    Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
    Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy.
    Goldenberg IF; Olivari MT; Levine TB; Cohn JN
    Am J Cardiol; 1989 Apr; 63(12):843-6. PubMed ID: 2929441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.